XML 28 R18.htm IDEA: XBRL DOCUMENT
v3.22.1

Stock-Based Compensation | 3 Months Ended
--- | ---
Mar. 29, 2022
Stock-Based Compensation |
Stock-Based Compensation | 10. Stock-Based Compensation ​ We maintain stock-based incentive plans under which incentive stock options, non-qualified stock options, stock appreciation rights, restricted shares and restricted share units may be granted to staff members, consultants and non-employee directors. The following table presents information related to stock-based compensation, net of forfeitures (in thousands): ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Thirteen | ​ | Thirteen
​ | ​ | Weeks Ended | ​ | Weeks Ended
​ |  | March 29, 2022 |  | March 30, 2021
​ | ​ | ​ | ​ | ​ | ​ | ​
Labor expenses | ​ | $ | 2,190 | ​ | $ | 2,043
Other operating costs and expenses | ​ |  | 76 | ​ |  | 74
General and administrative expenses | ​ |  | 3,252 | ​ |  | 3,327
Total stock-based compensation | ​ |  | 5,518 | ​ |  | 5,444
Income tax benefit | ​ |  | 1,355 | ​ |  | 1,337
Total stock-based compensation, net of taxes | ​ | $ | 4,163 | ​ | $ | 4,107
​ | ​ | ​ | ​ | ​ | ​ | ​
Capitalized stock-based compensation (1) | ​ | $ | 57 | ​ | $ | 39
(1) | It is our policy to capitalize the portion of stock-based compensation costs for our internal development department that relates to capitalizable activities such as the design and construction of new restaurants, remodeling existing locations and equipment installation. Capitalized stock-based compensation is included in property and equipment, net on the condensed consolidated balance sheets.
​ Stock Options We did not issue any stock options during the first quarter of fiscal 2022 or fiscal 2021. Stock option activity during the thirteen weeks ended March 29, 2022 was as follows:
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Weighted- | ​ | ​ | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | Average | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted- | ​ | Remaining | ​ | ​
​ | ​ | ​ | ​ | Average | ​ | Contractual | ​ | Aggregate
​ |  | Shares |  | Exercise Price |  | Term |  | Intrinsic Value (1)
​ | ​ | (In thousands) | ​ | (Per share) | ​ | (In years) | ​ | (In thousands)
Outstanding at December 28, 2021 | ​ | 1,716 | ​ | $ | 46.14 | ​ | 5.1 | ​ | $ | 0
Granted |  | — | ​ | ​ | — | ​ | ​ | ​ | ​ | ​
Exercised |  | (2) | ​ | ​ | 40.16 | ​ | ​ | ​ | ​ | ​
Forfeited or cancelled |  | (29) | ​ | ​ | 48.19 | ​ | ​ | ​ | ​ | ​
Outstanding at March 29, 2022 | ​ | 1,685 | ​ | $ | 46.11 | ​ | 4.9 | ​ | $ | 0
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Exercisable at March 29, 2022 |  | 1,114 | ​ | $ | 48.09 | ​ | 4.0 | ​ | $ | 0
(1) | Aggregate intrinsic value is calculated as the difference between our closing stock price at fiscal period end and the exercise price, multiplied by the number of in-the-money options and represents the pre-tax amount that would have been received by the option holders, had they all exercised their options on the fiscal period end date.
​ The total intrinsic value of options exercised during thirteen weeks ended March 29, 2022 and March 30, 2021 was $4.9 million and $5.7 million, respectively. As of March 29, 2022, total unrecognized stock-based compensation expense related to unvested stock options was $4.1 million, which we expect to recognize over a weighted-average period of approximately 2.4 years. ​ Restricted Shares and Restricted Share Units ​ Restricted share and restricted share unit activity during the thirteen weeks ended March 29, 2022 was as follows: ​
​ | ​ | ​ | ​ | ​ | ​
​ | ​ | ​ | ​ | Weighted-
​ | ​ | ​ | ​ | Average
​ |  | Shares |  | Fair Value
​ | ​ | (In thousands) | ​ | (Per share)
Outstanding at December 28, 2021 |  | 2,123 | ​ | $ | 44.82
Granted |  | 642 | ​ | ​ | 39.59
Vested |  | (258) | ​ | ​ | 48.16
Forfeited |  | (34) | ​ | ​ | 43.13
Outstanding at March 29, 2022 |  | 2,473 | ​ | $ | 43.13
​ Fair value of our restricted shares and restricted share units is based on our closing stock price on the date of grant. The weighted average fair value for restricted shares and restricted share units issued during the first quarter of fiscal 2022 and 2021 was $39.59 and $48.38, respectively. The fair value of shares that vested during the thirteen weeks ended March 29, 2022 and March 30, 2021 was $12.4 million and $9.5 million, respectively. As of March 29, 2022, total unrecognized stock-based compensation expense related to unvested restricted shares and restricted share units was $61.7 million, which we expect to recognize over a weighted-average period of approximately 3.3 years.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration